SYNTHETIC PEPTIDES PHARMACEUTICAL PURPOSES

Brand Owner (click to sort) Address Description
AQUATEIN NZ3 Inc 25 Bowker Street Lexington MA 024214142 Synthetic peptides for pharmaceutical purposes;Surfactants for use in the manufacture of synthetic detergents;
BIBRIDGED Biosynth B.V. ZUIDERSLUISWEG 2 LELYSTAD 8243 RC Netherlands Synthetic peptides for pharmaceutical purposes; peptides for pharmaceutical purposes; peptides for diagnostical purposes; peptides for diagnostical purposes in medical fields; peptides for serological purposes; peptides for radioimaging purposes in medical fields; peptides for use in the field of oncology; pharmaceutical preparations based on peptides; peptide mimics of antibodies;
CLIPS Biosynth B.V. ZUIDERSLUISWEG 2 LELYSTAD 8243 RC Netherlands Synthetic peptides for pharmaceutical purposes in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Synthetic peptides for the treatment of cancer, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders ; pharmaceutical preparations based on peptides in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; mimics consisting of peptides for antibodies;Inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product development; pharmaceutical product evaluation; pharmaceutical research and development services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; identifying peptides in the nature of pharmaceutical research and development; optimalization of peptides and synthetic peptides in the nature of pharmaceutical research and development; research and development services in the field of synthetic peptides and other pharmaceutical preparations;
CLIPS Pepscan Presto B.V. Zuidersluisweg 2 Lelystad 8243RC Netherlands Synthetic peptides for pharmaceutical purposes in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Synthetic peptides for the treatment of cancer, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders ; pharmaceutical preparations based on peptides in the nature of cancer treatment, treatment of inflammatory diseases, treatment of skin disorders, treatment of eye disorders; Diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; mimics consisting of peptides for antibodies;Inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product development; pharmaceutical product evaluation; pharmaceutical research and development services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; identifying peptides in the nature of pharmaceutical research and development; optimalization of peptides and synthetic peptides in the nature of pharmaceutical research and development; research and development services in the field of synthetic peptides and other pharmaceutical preparations;
KLIS SILK BIOMATERIALS S.R.L. Via Cavour, 2 Lomazzo (CO) 22074 Italy Synthetic peptides for pharmaceutical purposes; drug delivery agents; biological tissue for implantation; biological tissue cultures for medical purposes; chemical preparations for medical or veterinary purposes; biological preparations for medical purposes; medicines for human purposes;Surgical apparatus and instruments; medical apparatus and instruments; implantable subcutaneous drug delivery devices; biodegradable bone fixation implants; surgical implants comprised of artificial materials; hair prostheses; artificial implants; prosthetic implants; orthopaedic joint implants; implants [prostheses] for ligaments; artificial bones for implantation; orthopaedic fixation devices; devices for injecting pharmaceuticals; intravascular implants made from artificial materials; bone prostheses; dental prostheses; artificial vascular grafts; artificial joints; hip prostheses; implants [prosthesis] for dental surgery; medical apparatus; apparatus for the regeneration of stem cells for medical purposes; bone substitutes for surgical purposes; artificial bone parts to be implanted in natural bones; injection instruments without needles;Scientific research; medical research; biological, clinical and medical research; scientific and medical research and development; medical and pharmacological research services; scientific research for medical purposes; scientific services relating to the isolation and cultivation of human tissues and cells;
SIP Zealand Pharma A/S Sydmarken 11 Søborg DK-2860 Denmark Synthetic peptides for pharmaceutical purposes;Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;
SLIMATIDE Zealand Pharma A/S Sydmarken 11 Søborg DK-2860 Denmark Synthetic peptides for pharmaceutical purposes;SLIM A PEPTIDE;
THE BIO AFFINITY COMPANY Bac IP B.V. Huizerstraatweg 28 1411 GP Naarden Netherlands Synthetic peptides for pharmaceutical purposes; nutritive substances for mico-organisms for medical use;Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; protein arrays and nucleotide arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use;BIO AND COMPANY;Development of new technology for others in the field of biotechnology;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides synthetic chimeric fimbrin peptides which induce an immunogenic response in animals to non-typable Haemophilus influenzae and that do not require tedious purification techniques. The synthetic chimeric fimbrin peptides reduce the severity of otitis media caused by Haemophilus influenzae. The synthetic chimeric fimbrin peptides are synthesized using commercially available peptide synthesizers. The synthetic chimeric fimbrin peptides comprises three peptide units. The first peptide unit is a subunit of the fimbrin protein. Preferably, the fimbrin subunit is comprised of the amino acids of Sequence ID No. 1 or Sequence ID No. 2. The second peptide unit is a t cell epitope, and preferably has the amino acid sequence of SEQ ID NO. 3. The third peptide unit is a linker peptide unit which joins the first and second peptide unit. The linking sequence preferably has from about 2 to about 15 amino acids, more preferably from about 2 to about 10 amino acids, most preferably from about 5 to about 6 amino acids. The synthetic chimeric fimbrin peptides are useful immunognes against NTHi and also useful as laboratory tool for detecting antibodies in sera. The invention also relates to an immunogenic composition containing the synthetic chimeric fimbrin peptides and a pharmacologically acceptable carrier.